CXCL16 and thyroid gland papillary carcinoma: Associated with aggressive pathologic phenotypes, the higher TNM staging and lymph node metastasis in papillary thyroid cancer (51).Decrease of the overall survival due to CXCR6 overexpression, receptor of CXCL16 (52).